BioCardia, Inc. (BCDA) vs Palatin Technologies, Inc. (PTN)
A side-by-side comparison of BioCardia, Inc. and Palatin Technologies, Inc. across valuation, profitability, dividends, and growth — built entirely from reported fundamentals, as of October 6, 2026. Differences are shown without an overall score or investment verdict.
BCDA
BioCardia, Inc.
$1.08HealthcareDelayed quote: Oct 6, 2026, 1:00 PM EDT
PTN
Palatin Technologies, Inc.
$9.64HealthcareDelayed quote: Oct 6, 2026, 12:56 PM EDT
Total return — BCDA vs PTN
growth of $100 · dividends reinvested · last 10yBCDA -99.8% (-46.2%/yr)PTN -98.7% (-35.1%/yr)PTN compounded faster over this window
Log scale — wide-divergence pair
BCDA PTN
BCDA vs PTN: by the numbers
- •PTN is the larger company ($17M vs $16M market cap).
- •Both run net losses; BCDA's is the smaller (0.00% vs -63.54% net margin).
Metrics side by side
Valuation
| Metric | BCDA | PTN |
|---|---|---|
| P/S ratio | N/A | 1.30 |
| P/B ratio | 5.95 | 2.56 |
Profitability
| Metric | BCDA | PTN |
|---|---|---|
| Gross margin | 0.00% | 99.63% |
| Operating margin | 0.00% | -65.74% |
| Net margin | 0.00% | -63.54% |
| ROE | -271.81% | -125.30% |
| ROIC | -273.70% | -125.44% |
Growth (annualized)
| Metric | BCDA | PTN |
|---|---|---|
| Total return CAGR (5Y) | -61.39% | -55.41% |
Frequently asked
- How have BCDA and PTN total returns compared?
- Over the past 10 years, BCDA delivered -46.74% and PTN delivered -35.08% annualized total return. Past performance doesn't predict future results.
Go deeper
Dig into the metrics
Figures are sourced from reported fundamentals and the latest end-of-day price. This comparison is informational only and is not investment advice. Past performance does not predict future results. See our methodology. Compiled by TGMCharts Research · data verified October 6, 2026.